Alexander Archibald Dobbie
Founder at Cogency Chemical Consultants Ltd.
Profile
Alexander Archibald Dobbie is the founder of Cogency Chemical Consultants Ltd., which was founded in 2001.
He held the title of Director from 2011 to present.
Currently, he is the Chairman of Chemical Sciences Scotland.
Dr. Dobbie's former positions include Chairman of Warwick International Group Ltd., Chairman-Supervisory Board of Evolva SA, Non-Executive Director of Synthomer Plc from 2007 to 2012, Principal of Merck & Co., Inc., Executive Vice President of Octel Corp., and Principal of Brent International Plc.
Alexander Archibald Dobbie active positions
Companies | Position | Start |
---|---|---|
Cogency Chemical Consultants Ltd.
Cogency Chemical Consultants Ltd. Miscellaneous Commercial ServicesCommercial Services Cogency Chemical Consultants Ltd. is a specialist advisor offering analysis of key issues likely to affect the success of M&A deals in the chemicals and related industries. It also offers strategic and commercial advice on international chemical sector transactions. The company was founded by Philip R. Morrish, Stephen Richard Butler, Alexander Archibald Dobbie, and Paul Leonard Smith in 2001 and is headquartered in Nuneaton, the United Kingdom. | Founder | 31/12/2000 |
Chemical Sciences Scotland | Chairman | 01/09/2010 |
Former positions of Alexander Archibald Dobbie
Companies | Position | End |
---|---|---|
SYNTHOMER PLC | Director/Board Member | 16/05/2012 |
Octel Corp. | Corporate Officer/Principal | 30/01/2006 |
Warwick International Group Ltd.
Warwick International Group Ltd. Chemicals: SpecialtyProcess Industries Warwick International Group Ltd. manufactures and distributes oxygen-based bleaching systems. Its products include detergents, automatic dishwashing, bleach boosters and biocidal products. The company was founded in 1958 and is headquartered in Holywell, the United Kingdom. | Chairman | - |
Brent International Plc | Corporate Officer/Principal | - |
MERCK & CO., INC. | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
MERCK & CO., INC. | Health Technology |
SYNTHOMER PLC | Process Industries |
Private companies | 6 |
---|---|
Octel Corp. | Process Industries |
Brent International Plc | Process Industries |
Warwick International Group Ltd.
Warwick International Group Ltd. Chemicals: SpecialtyProcess Industries Warwick International Group Ltd. manufactures and distributes oxygen-based bleaching systems. Its products include detergents, automatic dishwashing, bleach boosters and biocidal products. The company was founded in 1958 and is headquartered in Holywell, the United Kingdom. | Process Industries |
Evolva SA
Evolva SA Miscellaneous Commercial ServicesCommercial Services Evolva SA is a Swiss-headquartered, international pharmaceutical biotech company focused on the discovery and development of drugs based on its distinctive and proprietary genetic chemistry platform. The company was founded in Switzerland in 2004 based on US/Danish technology. Evolva is headquartered in Allschwil/Basel with operations in Denmark, India and the USA. The Company has raised CHF 38.2 million of equity to date and employs 75 persons of whom 30 are based in Allschwil. The firm's strategy and business approach is based on five pillars that offer a sustainable development path for creating a successful company, which include Building a balanced portfolio. Evolva focuses on orally available small molecules in the belief that they are more convenient for patients and more cost-effective both from manufacture and administration points of view for the society, focus on differentiated pharmaceutical products with major benefits. Focusing on cardiovascular/renal and infectious diseases. Together they cause more than 50% of all deaths worldwide. Most of the top 20 pharmaceutical companies are active in both sectors, and all are active in one of the two sectors - hence widening Evolva's opportunities to partner. Building technology platform as the source of this differentiation. Evolva finds different structures with different properties from those found by the 99% of the industry that focuses on synthetic chemistry or proteins. Openness to unusual markets. The biotech business model has changed. As well as the established markets new opportunities arise in emerging countries such as India and China, and in adjacent sectors such as treatments against potential bio-terrorist and bio-warfare agents and the production of pharmaceutical and industrial chemical intermediates. Cost-effective implementation. Evolva places different functions around the globe according to where local conditions best suit. This approach both reduces Evolva's cost base and increases access to revenues, partners and talent. Evolva sees revenues and partners as important because they provide additional flexibility, resources and talent. Also, they provide important opportunities to better understand, and better meet, the needs of current and future customers. | Commercial Services |
Cogency Chemical Consultants Ltd.
Cogency Chemical Consultants Ltd. Miscellaneous Commercial ServicesCommercial Services Cogency Chemical Consultants Ltd. is a specialist advisor offering analysis of key issues likely to affect the success of M&A deals in the chemicals and related industries. It also offers strategic and commercial advice on international chemical sector transactions. The company was founded by Philip R. Morrish, Stephen Richard Butler, Alexander Archibald Dobbie, and Paul Leonard Smith in 2001 and is headquartered in Nuneaton, the United Kingdom. | Commercial Services |
Chemical Sciences Scotland |
- Stock Market
- Insiders
- Alexander Archibald Dobbie